Skip to content

Access For All

Recent advances in life-saving technologies have allowed for better health outcomes and an improved quality of life for those living with type 1 diabetes. Despite advancements, many of these technologies, like advanced glucose monitors and insulin pumps, are expensive and remain out of reach and inaccessible for Canadians. Through JDRF’s work in advocacy, we are supporting the T1D community to make their voices heard and moving towards the goal of equitable access across Canada.

The #AccessForAll Campaign was launched in 2019 to increase public and private coverage for insulin pumps and advanced glucose monitors and reduce the out-of-pocket costs of living with T1D. 2021 saw a high number of positive announcements from jurisdictions across Canada increasing public coverage of advanced glucose monitors:

British Columbia

Flash GM Coverage: Not covered

CGM Coverage: Announced in June 2021

Yukon

Flash GM Coverage: Announced in September 2020

CGM Coverage: Announced in January 2020

Saskatchewan

Flash GM Coverage: Announced in April 2021

CGM Coverage: Announced in April 2021

Alberta

Flash GM Coverage: Announced in December 2017

CGM Coverage: Announced in February 2022

Ontario

Flash GM Coverage: Announced in November 2021

CGM Coverage: Announced in March 2022

Manitoba

Flash GM Coverage: Announced in September 2021

CGM Coverage: Announced in September 2021

Québec

Flash GM Coverage: Announced in 2019

CGM Coverage: Announced in May 2021

PEI

Flash GM Coverage: Announced in May 2022

CGM Coverage: Announced in May 2022

Since the launch of #AccessForAll in 2019, new coverage announcements have been made in 7 provinces and 1 territory, impacting 199,500 lives. This coverage is helping those living with T1D save out of pocket costs on devices. Per year, CGMs can range from $3,000-$6,000, Flash GMs approximately $2,500 and insulin pumps from $6,000-$8,000.

While these announcements are significant for the T1D community, coverage is limited by age in many instances and more progress on public coverage needs to be made in the Atlantic region. Patient choice is also a significant issue that needs to be addressed. As the campaign continues, JDRF remains committed to advocating on behalf of every Canadian impacted by T1D to make these technologies affordable and accessible for everyone.

29 meetings with elected officials

614 letters sent by JDRF and our community of advocates

Previous Page

JDRF’s Advocacy Works to Ensure the T1D Community is Supported: Overview

Contact

Address

JDRF National Support Office

235 Yorkland Blvd. Suite 600

Toronto ON, M2J 4Y8

Phone

TF: 1.877.287.3533

TEL: 647.789.2000

FAX: 416.491.2111

Web

jdrf.ca

©2022 JDRF Impact Report 2021. Report by floating-point.

Charitable Registration # 11897 6604 RR0001